PT2906213T - Um método veterinário para aliviar a aversão ao rúido - Google Patents

Um método veterinário para aliviar a aversão ao rúido

Info

Publication number
PT2906213T
PT2906213T PT137890224T PT13789022T PT2906213T PT 2906213 T PT2906213 T PT 2906213T PT 137890224 T PT137890224 T PT 137890224T PT 13789022 T PT13789022 T PT 13789022T PT 2906213 T PT2906213 T PT 2906213T
Authority
PT
Portugal
Prior art keywords
veterinary method
alleviating noise
noise aversion
aversion
alleviating
Prior art date
Application number
PT137890224T
Other languages
English (en)
Inventor
Kokkonen Johanna
Korpivaara Mira
Sarén Nina
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of PT2906213T publication Critical patent/PT2906213T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT137890224T 2012-10-15 2013-10-14 Um método veterinário para aliviar a aversão ao rúido PT2906213T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261713858P 2012-10-15 2012-10-15

Publications (1)

Publication Number Publication Date
PT2906213T true PT2906213T (pt) 2018-02-19

Family

ID=49553730

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137890224T PT2906213T (pt) 2012-10-15 2013-10-14 Um método veterinário para aliviar a aversão ao rúido

Country Status (22)

Country Link
US (1) US10780079B2 (pt)
EP (1) EP2906213B1 (pt)
JP (1) JP6224115B2 (pt)
KR (1) KR102146690B1 (pt)
CN (1) CN104797252B (pt)
AU (1) AU2013333787B2 (pt)
BR (1) BR112015008459B1 (pt)
CA (1) CA2884926C (pt)
DK (1) DK2906213T3 (pt)
ES (1) ES2659271T3 (pt)
HK (1) HK1212607A1 (pt)
HR (1) HRP20180479T1 (pt)
HU (1) HUE037272T2 (pt)
LT (1) LT2906213T (pt)
MX (1) MX368880B (pt)
NZ (1) NZ706990A (pt)
PL (1) PL2906213T3 (pt)
PT (1) PT2906213T (pt)
RU (1) RU2638804C2 (pt)
SI (1) SI2906213T1 (pt)
WO (1) WO2014060638A1 (pt)
ZA (1) ZA201502311B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT513535B1 (de) 2014-02-06 2015-09-15 Avl List Gmbh Verfahren zur Funktionsprüfung einer Anordnung zur dynamischen Kraftstoffverbrauchsmessung
JP7065871B2 (ja) * 2016-12-13 2022-05-12 オリオン コーポレーション イヌの分離不安症の治療における使用のためのデクスメデトミジンまたはメデトミジン
EP3562486B1 (en) 2016-12-31 2024-03-13 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
BR112020026672A2 (pt) 2018-06-27 2021-03-30 Bioxcel Therapeutics, Inc. Formulações de filme contendo dexmedetomidina e métodos para produzi-las
US10849729B2 (en) * 2019-04-16 2020-12-01 The Procter & Gamble Company Multi-phase oral care compositions
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
CN117157070A (zh) 2021-03-19 2023-12-01 奥赖恩公司 他西匹啶(tasipimidine)制剂及其用途
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6716867B1 (en) * 1998-04-01 2004-04-06 Orion Corporation Use of dexmedetomidine for ICU sedation
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
TW200719895A (en) * 2005-05-26 2007-06-01 Wyeth Corp Method for the treatment of noise phobia in companion animals
WO2009012082A1 (en) * 2007-07-17 2009-01-22 Allergan, Inc. Methods for treating anxiety
RU2572692C2 (ru) * 2009-05-15 2016-01-20 Рекро Фарма, Инк. Сублингвальные композиции дексмедетомидина и способы их применения

Also Published As

Publication number Publication date
EP2906213A1 (en) 2015-08-19
CA2884926C (en) 2021-09-21
RU2015118162A (ru) 2016-12-10
NZ706990A (en) 2017-12-22
HK1212607A1 (zh) 2016-06-17
ES2659271T3 (es) 2018-03-14
SI2906213T1 (en) 2018-02-28
DK2906213T3 (en) 2018-02-19
HUE037272T2 (hu) 2018-08-28
CN104797252A (zh) 2015-07-22
ZA201502311B (en) 2016-01-27
AU2013333787A1 (en) 2015-04-09
RU2638804C2 (ru) 2017-12-15
US10780079B2 (en) 2020-09-22
AU2013333787B2 (en) 2017-06-08
EP2906213B1 (en) 2018-01-03
HRP20180479T1 (hr) 2018-05-04
CN104797252B (zh) 2016-09-21
WO2014060638A8 (en) 2014-06-05
JP2015533153A (ja) 2015-11-19
MX2015004747A (es) 2015-07-21
BR112015008459B1 (pt) 2020-11-10
US20150258067A1 (en) 2015-09-17
JP6224115B2 (ja) 2017-11-01
MX368880B (es) 2019-10-21
BR112015008459A2 (pt) 2017-07-04
CA2884926A1 (en) 2014-04-24
KR20150071027A (ko) 2015-06-25
WO2014060638A1 (en) 2014-04-24
KR102146690B1 (ko) 2020-08-24
LT2906213T (lt) 2018-02-26
PL2906213T3 (pl) 2018-04-30

Similar Documents

Publication Publication Date Title
HK1215799A1 (zh) 用於化合物遞送的方法和設備
ZA201405540B (en) Packaging and method of packaging
GB2500978B (en) A Method of Compressing a Graph Representation
GB201219729D0 (en) Device and method of forming a device
PL2825719T3 (pl) Sposób obsługi odwiertów
PL2730878T3 (pl) Pakiet płyt i metoda wykonania pakietu płyt
HK1212607A1 (zh) 減輕噪音厭惡的獸醫方法
EP2836221A4 (en) METHOD OF USING CYCLODEXTRIN
IL233596B (en) A method to prevent allergies
GB201208548D0 (en) Compound and method
GB201207208D0 (en) Compound and method of manufacture
PL2931937T3 (pl) Sposób wytwarzania układów nanocząstek metali
EP2875348A4 (en) METHOD OF ISOLATING MICROVESICLES
GB201220155D0 (en) Method of manufacture
IL237862A0 (en) Methods to reduce the formation of scale
IL235805A (en) Pyrimidinyl-Diazaspiro compound and process for preparation
GB2509246B (en) Component and method of formation thereof
EP3457439C0 (en) ELECTRONIC DEVICES
GB201405377D0 (en) Compound, device and method of making same
IL236154A0 (en) compound and method
EP2868030A4 (en) REVISION OF A DEVICE
GB201215942D0 (en) Method of treatent
GB201217309D0 (en) Packaging and method of making packaging
HK1208864A1 (en) A preparation method of ecteinascidin-743 intermediate -743
EP2940011A4 (en) PREPARATION FOR HALOHYDRANTOINE COMPOUND AND HALOHYDRANTOINE COMPOUND